H.B. Fuller insider exercise and sale reduces direct holdings to 3,285 shares
Rhea-AI Filing Summary
Joao Magalhaes, Sr. VP, Engineering Adhesives at H.B. Fuller (FUL), reported an employee option exercise and an offsetting share sale on 08/08/2025. He exercised 1,099 fully vested options with a $33.38 exercise price and sold 1,099 shares at $56.315. Following these transactions his direct beneficial ownership declined from 4,384 shares to 3,285 shares. Table II lists multiple outstanding option grants and restricted stock units, including an 8,853-share option at a $61.30 strike and RSU grants of 130.22, 301.33 and 1,562.29 shares (some RSUs include dividend-equivalent reinvestment). The Form 4 documents a routine exercise and sale and provides the current option and RSU holdings disclosed by the reporting person.
Positive
- Exercised a 100% vested option: 1,099 options exercised at $33.38 (explicitly marked as fully vested)
- Continues to hold direct shares and long-dated awards: retains 3,285 direct shares and multiple outstanding option grants and RSUs are disclosed (including an 8,853-share option)
Negative
- Insider sale recorded: sold 1,099 shares at $56.315, reducing direct beneficial ownership from 4,384 to 3,285
- Reduction in direct holdings: net direct share count declined by 1,099 shares following the transactions
Insights
TL;DR: Routine option exercise and sale reduced direct holdings to 3,285 shares; several outstanding grants remain.
The Form 4 shows a paired exercise and sale on 08/08/2025: 1,099 vested options were exercised at $33.38 and 1,099 shares sold at $56.315, reducing direct holdings from 4,384 to 3,285 shares. The realized spread between sale price and exercise price is explicit in the filing. Table II documents multiple remaining option grants with various strikes and maturities and listed RSU awards. For investors this is a disclosure of insider liquidity activity and the reporting person’s remaining equity exposure; it does not, by itself, indicate a change in corporate outlook or governance.
TL;DR: Transactions align with compensation vesting and option exercise mechanics; several long-dated grants and RSUs remain outstanding.
The filing identifies one option grant that was 100% vested and exercised, plus many outstanding grants across multiple grant dates and strike prices. Notable listed instruments include an 8,853-share option at a $61.30 strike exercisable 02/04/2026 and multiple RSU grants that vest over time. The Form 4 therefore documents normal equity compensation activity and current beneficial ownership details rather than corporate governance changes.